Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Aug. 31, 2021

TroBio Therapeutics presents new compounds for cancer

Aug. 31, 2021

Janssen Biotech divulges DHODH inhibitors

Aug. 31, 2021

TH-1902, a new docetaxel-peptide conjugate with efficacy in SORT1-positive TNBC models

Aug. 30, 2021

CELMoD CC-99282 for hematological malignancies

Aug. 30, 2021

Bristol Myers Squibb identifies new Toll-like receptor 7 agonists

Aug. 30, 2021

First-in-human study planned with NXP-800 in advanced cancers

Aug. 27, 2021

Unnatural Products targets MDM2 and MDM4 with macrocylic peptides

Aug. 27, 2021

Chinese clearance for phase Ib/III trial of afuresertib with fulvestrant in HR+, HER- breast cancer

Aug. 27, 2021

BioTheryX presents PROTACs including casein kinase I isoform alpha degradation inducers

Aug. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.